ACADIA Pharmaceuticals In... (ACAD)
NASDAQ: ACAD
· Real-Time Price · USD
25.30
0.77 (3.14%)
At close: Aug 15, 2025, 3:59 PM
25.33
0.12%
After-hours: Aug 15, 2025, 04:04 PM EDT
ACADIA Pharmaceuticals Balance Sheet Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Cash & Equivalents | 253.64M | 217.7M | 319.59M | 155.15M | 177.13M | 204.75M | 188.66M | 98.19M | 107.94M | 290.89M | 114.85M | 154.84M | 139.83M | 204.92M | 147.44M | 94.64M | 266.96M | 304.49M |
Short-Term Investments | 508.36M | 463.88M | 436.4M | 410.18M | 323.81M | 265.77M | 250.21M | 247.73M | 267.44M | 111.98M | 301.98M | 281.74M | 296.52M | 241.06M | 373.27M | 445.65M | 289.96M | 273.28M |
Long-Term Investments | 9.47M | n/a | n/a | n/a | 5.77M | 5.77M | 5.77M | 5.77M | 8.12M | 5.77M | 12.97M | n/a | 5.77M | 5.77M | 9.37M | 5.77M | 5.77M | 5.77M |
Other Long-Term Assets | 86.66M | 90.25M | 78.87M | 34.83M | 15.02M | 10.95M | 5.1M | 10.87M | 24.35M | 23.13M | 5.31M | 17.8M | 10.04M | 10.54M | 6.61M | 2.37M | 1.99M | 1.81M |
Receivables | 119.69M | 113.71M | 104.69M | 98.21M | 110.39M | 100.08M | 102.35M | 94.53M | 84.16M | 70.25M | 63.08M | 56.14M | 68.89M | 63.48M | 65.34M | 61.67M | 51.82M | 57.39M |
Inventory | 26.12M | 22.95M | 21.95M | 61.04M | 71.53M | 61.94M | 35.82M | 20.77M | 9.2M | 6.09M | 6.64M | 5.84M | 6.33M | 7.01M | 7.88M | 14.34M | 10.79M | 10.31M |
Other Current Assets | n/a | n/a | n/a | 12.15M | n/a | 48.14M | n/a | 39.68M | n/a | 27.97M | n/a | 23.4M | n/a | n/a | n/a | n/a | n/a | n/a |
Total Current Assets | 960.55M | 870.94M | 938.32M | 788.28M | 728.92M | 675.3M | 616.13M | 499.17M | 492.63M | 502.85M | 507.94M | 521.55M | 532.52M | 542.22M | 617.82M | 640.92M | 645.73M | 673.98M |
Property-Plant & Equipment | 54.54M | 54.11M | 50.79M | 48.24M | 56.53M | 58.65M | 56.47M | 55.64M | 57.58M | 59.75M | 61.59M | 63.13M | 64.43M | 65.72M | 66.31M | 68.61M | 70.57M | 72.87M |
Goodwill & Intangibles | 114.34M | 117.06M | 119.78M | 105.52M | 107.86M | 110.2M | 65.49M | 66.86M | 68.22M | 69.58M | n/a | n/a | n/a | n/a | n/a | n/a | 369K | 738K |
Total Long-Term Assets | 265M | 261.42M | 249.44M | 188.58M | 185.18M | 179.81M | 132.83M | 133.37M | 150.14M | 152.46M | 79.88M | 80.94M | 80.25M | 82.03M | 82.3M | 76.76M | 78.7M | 81.19M |
Total Assets | 1.23B | 1.13B | 1.19B | 976.87M | 914.1M | 855.1M | 748.96M | 632.54M | 642.77M | 655.3M | 587.81M | 602.49M | 612.77M | 624.25M | 700.12M | 717.67M | 724.43M | 755.17M |
Account Payables | 20.1M | 18.09M | 16.19M | 19.08M | 19.88M | 19.33M | 17.54M | 12.31M | 18.81M | 17.42M | 12.75M | 10.01M | 11.85M | 10.77M | 6.88M | 7.72M | 9.06M | 8.85M |
Deferred Revenue | n/a | n/a | n/a | n/a | 8.46M | -10.45M | 1.56M | -9.03M | -9.06M | n/a | n/a | -9.23M | n/a | n/a | n/a | n/a | n/a | n/a |
Short-Term Debt | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Current Liabilities | 309.93M | 25.26M | 36.55M | 315.92M | 273M | 274.75M | 92.31M | 145.65M | 134.66M | 176.51M | 49.51M | 68.54M | 73.45M | 78.25M | 39.27M | 50.56M | 57.45M | 72.67M |
Total Current Liabilities | 330.02M | 302.53M | 394.87M | 343.94M | 337.85M | 330.6M | 254.25M | 209.6M | 187.94M | 224.3M | 125.63M | 116.57M | 117.68M | 119.6M | 96.07M | 88.22M | 95.33M | 109.37M |
Long-Term Debt | 44.6M | n/a | n/a | 40.42M | 47.19M | 49.19M | n/a | 48.1M | 49.78M | 51.44M | n/a | 53.77M | 54.69M | 55.48M | 56.13M | 57.68M | 59.13M | 60.58M |
Other Long-Term Liabilities | 28.55M | 19.96M | 18.06M | 15.32M | -34.82M | -37.92M | 15.15M | -35.44M | -40.52M | -46.14M | 9.07M | -47.3M | -49.15M | -51.1M | -49.09M | -52.85M | -54.01M | -56.97M |
Total Long-Term Liabilities | 73.15M | 64.6M | 60.09M | 55.74M | 59.55M | 60.46M | 62.95M | 60.76M | 59.03M | 56.75M | 61.77M | 60.23M | 60.24M | 59.85M | 63.16M | 62.5M | 64.26M | 64.19M |
Total Liabilities | 403.17M | 367.13M | 454.96M | 399.69M | 397.4M | 391.06M | 317.2M | 270.37M | 246.98M | 281.05M | 187.4M | 176.81M | 177.92M | 179.45M | 159.23M | 150.72M | 159.59M | 173.57M |
Total Debt | 44.6M | 56.01M | 51.99M | 49.37M | 57.66M | 59.64M | 57.2M | 48.1M | 49.78M | 51.44M | 62M | 53.77M | 63.72M | 64.42M | 56.13M | 57.68M | 59.13M | 60.58M |
Common Stock | 16K | 16K | 16K | 16K | 16K | 16K | 16K | 16K | 16K | 16K | 16K | 16K | 16K | 16K | 16K | 16K | 16K | 16K |
Retained Earnings | -2.16B | -2.19B | -2.2B | -2.35B | -2.38B | -2.41B | -2.43B | -2.48B | -2.41B | -2.41B | -2.37B | -2.33B | -2.3B | -2.27B | -2.15B | -2.11B | -2.1B | -2.05B |
Comprehensive Income | 406K | 437K | 292K | 858K | -339K | -229K | 24K | -319K | -535K | -220K | -975K | -1.36M | -843K | -612K | -192K | -1K | 38K | 34K |
Shareholders Equity | 822.38M | 765.24M | 732.79M | 577.18M | 516.7M | 464.04M | 431.75M | 362.17M | 395.79M | 374.26M | 400.41M | 425.69M | 434.85M | 444.8M | 540.89M | 566.96M | 564.84M | 581.61M |
Total Investments | 9.47M | 463.88M | 436.4M | 410.18M | 329.58M | 265.77M | 255.98M | 247.73M | 267.44M | 111.98M | 301.98M | 281.74M | 296.52M | 241.06M | 373.27M | 445.65M | 289.96M | 273.28M |